News

MDC researchers established a new model to study neuromuscular development and disorders. For the first time two distinct human tissues co-developed in the lab from one progenitor cell type and self-organized into a complex, functional neuromuscular organoid.

How to save a functionally extinct species, animal testing in neurobiology, and innovative new cancer therapies – these are just some of the topics covered in the lectures series “New Avenues in Biomedicine.” The series, which includes contributions from three MDC researchers, offers the general public a lens into what’s happening in the world of science.

What does a protein forming the cell’s nuclear envelope have to do with a dangerous heart condition? Aided by stem cell experiments, a team of researchers from Stanford University and the MDC recently answered this question.

Jennifer Pocock from University College London spoke at the Elena Timoféeff Ressovsky lecture on 20 June 2019.

With its large-scale research project BioRescue, the German Federal Ministry of Education and Research (BMBF ) is funding research into the artificial reproduction of the functionally extinct northern white rhino. MDC researchers are among the project partners working together to create new animals from skin cells.

The artist Emilia Tikka spent three months as a guest in the MDC labs to gather inspiration for her work “ÆON. Trajectories of Longevity and CRISPR.”

During the "Long Night of Sciences" on June 15, visitors can see something that hardly anyone has seen before - simply because it is still so new: spinal cord neurons and skeletal muscle tissue that have been cultivated together from stem cells.

When an American physician from the field of patient-directed translational research and a German basic researcher meet, that encounter can take them in many possible directions. In the case of Professor David Gutmann and Professor Helmut Kettenmann, it led to a merging of their respective research teams.

The artist Emilia Tikka spent three months at MDC labs. She was curious about CRISPR and whether genetic reprogramming could enable a “rejuvenation” of human cells in the future. Now, the results of her residency called “AEON – Trajectories of Longevity and CRISPR” are being shown at STATE Studio Berlin.

Switching off “safeguard” genes improves cell reprogramming, aiding future regenerative therapies.